Glutathione Oral, Liposomal and Sublingual Forms: What Evidence Exists
What small studies found about oral, liposomal, sublingual and dissolving-film glutathione, why blood levels are not health benefits, and the limits of company-linked research.
Content last updated . This page has not been medically reviewed.
Quick answer
Several small studies measured how much glutathione shows up in blood after different forms. Some found higher levels with newer forms. None of the studies read here showed that any form prevents or treats a disease. Blood glutathione is a biomarker (a lab measure), not a health outcome. No products are named or ranked on this page.
How the terms are used
- Oral (standard): a capsule or tablet that is swallowed.
- Liposomal: glutathione packed inside tiny fat-like bubbles in a liquid or capsule.
- Sublingual / orobuccal: held under the tongue or in the cheek to dissolve.
- Dissolving film: a thin strip that melts in the mouth.
- Bioavailability: how much of a dose reaches the blood. Researchers describe oral glutathione's availability as controversial. [1]
Why absorption is a question
Authors of one study explain that the gut can break glutathione down (via an enzyme called gamma-glutamyltransferase), so dietary glutathione is not a major determinant of raising levels. [2] Authors of a 2026 study describe oral glutathione's use as limited by gut degradation and low membrane permeability, which is the reason newer forms are being tested. [3]What the studies found
| Form compared | Population and design | What the source found | Strength of evidence |
|---|---|---|---|
| Plain oral capsule, 6 months | 54 non-smoking adults, randomized, placebo-controlled, 250 or 1,000 mg/day | Glutathione rose 30 to 35% in several blood cell types in the high-dose group and returned to baseline after a 1-month washout. [4] | Biomarker only |
| Standard vs newer micellar form, single dose | 14 healthy adults, randomized crossover | The newer form gave about 2.5-fold higher incremental blood exposure than the standard form at the doses given; a 30-day follow-up found no significant changes in liver and kidney markers. [5] | Biomarker only; small pilot |
| Plain vs liposomal, single dose | 12 healthy people, open-label, 6 per group | The liposomal product reached higher plasma levels (about 6 times higher than plain) in this small study. [3] | Biomarker only; very small |
| Dissolving film vs tablet | Healthy adults, crossover plus 4 weeks | Plasma glutathione was higher with the film at 4 and 6 hours; after 4 weeks both increased levels with no significant change in oxidative stress-related biomarkers. [1] | Biomarker only |
| Sublingual vs oral vs NAC | 20 volunteers with metabolic syndrome, 3-week crossover | Higher total and reduced glutathione and a higher GSH/GSSG ratio with the sublingual form than oral glutathione. [6] | Biomarker only |
| Orobuccal tablet | 15 healthy volunteers | Authors reported higher blood glutathione 30 and 60 minutes after use. [2] | Biomarker only |
| Sublingual in lung disease (COPD) | 50 people, usual treatment with or without sublingual glutathione for 2 months | Inflammation markers fell in both groups; the difference between groups was not statistically significant. [7] | Insufficient evidence |
Frequently asked questions
Is liposomal glutathione absorbed better?
In one very small single-dose study, plasma levels were higher than with plain glutathione. [3] That is a blood measure, not proof of benefit.
Does sublingual glutathione work?
One 3-week crossover study found higher blood glutathione than the oral form in 20 volunteers. [6] A COPD study found no significant group difference in inflammation markers. [7]
Does higher blood glutathione mean better health?
No. The studies read measured levels, not disease outcomes. [4]
Are glutathione drips the same?
No. IV use is a separate medical-setting topic; see the injections page linked above.
Can I trust the studies?
They are small and some tested branded products, so treat them as early lab data. [5]
More details: evidence, limits and cautions
The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.
Limits and uncertainty
- Biomarker is not outcome. None of these studies measured fewer infections, longer life, clearer skin or disease control. In the 4-week film study, oxidative stress biomarkers did not significantly change. [1]
- Small, short and often single-dose. Studies of 12 to 20 people cannot rank forms. The 3-week and single-dose designs cannot show long-term effects.
- Company links. Several studies tested branded formulations (not named here). [5] Authors of the sublingual study list a laboratory company among their affiliations, and authors of the single-dose liposomal study list a company affiliation. [6][3] Independent replication was not found: proper evidence not found in our PubMed search for independent head-to-head trials of liposomal versus plain glutathione with health outcomes.
- Do not transfer across forms. A result for one product does not apply to another liposomal or sublingual product, and animal or cell-based results (including mouse studies) are preclinical.
Safety and who should ask first
The studies were short and small; a 30-day follow-up of 14 people found no significant changes in liver and kidney markers for the product tested. [5] Proper evidence not found for long-term safety, pregnancy, breastfeeding, children, kidney or liver disease, or medicine interactions. During cancer treatment a systematic review reported antioxidants might impair tumor control, so tell your oncology team about any supplement. [8] Ask a clinician or pharmacist, and see medication interactions, supplements before surgery, reading supplement labels and quality testing and certifications.
Related: glutathione, glutathione side effects, interactions and safety, NAC vs glutathione, injections and IV drips.
References
- Jung ES, et al. Formulation-dependent differences in systemic glutathione availability: comparative pharmacokinetics of orally dissolving film and tablet formulations in healthy adults. Eur J Pharm Biopharm 2026. Read 2026-10-22.
- Buonocore D, et al. Bioavailability study of an innovative orobuccal formulation of glutathione. Oxid Med Cell Longev 2016. Read 2026-10-22.
- Prasad KN, et al. Liposomal glutathione outperforms plain glutathione in uptake, cell regeneration and systemic availability: evidence from cellular and human models. Br J Nutr 2026. Read 2026-10-22.
- Richie JP Jr, et al. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. Eur J Nutr 2015. Read 2026-10-22.
- Solnier J, et al. A Targeted Metabolomic Assessment of Oral Glutathione Bioavailability and Safety in Humans: A Randomized Crossover Clinical Trial. Antioxidants (Basel) 2026. Read 2026-10-22.
- Schmitt B, et al. Effects of N-acetylcysteine, oral glutathione (GSH) and a novel sublingual form of GSH on oxidative stress markers: a comparative crossover study. Redox Biol 2015. Read 2026-10-22.
- Farag A, et al. Evaluation of the antioxidant and anti-inflammatory effect of sublingual glutathione on COPD patients. J Med Life 2023. Read 2026-10-22.
- Limbrunner J, et al. The influence of antioxidant supplementation on adverse effects and tumor interaction during radiotherapy: a systematic review. Clin Exp Med 2025. Read 2026-10-22.
Education, not medical advice. This page is for general information. It does not diagnose or treat any condition and is not a substitute for care from a qualified health professional. Natural does not automatically mean safe. Ask a clinician or pharmacist before changing your care, especially if you take medication, are pregnant or breastfeeding, or have a health condition.